The Health Innovation Network’s National Lipid Optimisation & Familial Hypercholesterolaemia (FH) Programme has delivered huge impact in its goal to reduce the prevalence of cardiovascular disease and its associated health inequalities, according to the programme’s new Impact Report.
The report celebrates the collective achievements of the programme, which has increased the detection of people with FH, improved lipid management outcomes, and driven awareness and action with healthcare professionals and our populations about the importance of cholesterol in cardiovascular risk.
Led by Health Innovation North East and North Cumbria, the programme involved the implementation of NICE endorsed national guidance for lipid management and prevention of cardiovascular disease.
Lesley Bull, a South London GP and our 1000th delegate chats to Lois-Hooper Ainsworth, Programme Coordinator on the National Polypharmacy Programme, about why she registered for the Health Innovation Network Polypharmacy Action Learning Set, what she got out of it and why other GPs should attend. Lesley Bull So, Lesley, could you tell [...]
Jo Barosa is Account Director at Qbtech UK. Qbtech is a market leading provider of innovative objective tests for assessing and treating ADHD, changing the landscape of ADHD care. Driven by its mission to improve the lives of people with ADHD, Qbtech supports by providing digital and clinical solutions to improve clinical decision making, service [...]
Dr Cheryl Crocker, interim Chief Operating Officer at the Health Innovation Network, explains the vital role innovation plays to not only reduce waiting lists and improve access to care, but to decrease system pressure by improving people’s health and keeping them well for longer. The new Government has rightly declared its focus on moving the [...]
